Alpha Tau Medical (NASDAQ:DRTSW) Trading Down 2.2% – Should You Sell?

Alpha Tau Medical Ltd. (NASDAQ:DRTSW)’s share price traded down 2.2% during trading on Wednesday . The stock traded as low as $1.10 and last traded at $1.1250. 15,291 shares changed hands during mid-day trading, a decline of 79% from the average session volume of 71,665 shares. The stock had previously closed at $1.15.

Alpha Tau Medical Stock Performance

The company has a fifty day moving average price of $0.72 and a two-hundred day moving average price of $0.45.

About Alpha Tau Medical

Alpha Tau Medical Ltd. is a clinical-stage medical technology company focused on the development of alpha-emitting radiation therapy for the treatment of solid tumor cancers. The company’s proprietary Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) platform leverages the short-range, high-energy alpha particles emitted by radium-224 to penetrate tumor tissues more effectively than conventional external-beam radiation. By implanting thin, needle-like sources directly into a tumor, Alpha DaRT delivers concentrated doses of radiation to malignant cells while sparing surrounding healthy tissue.

The Alpha DaRT technology is designed to enhance local tumor control in a variety of solid tumors, including head and neck, breast, skin, and pancreatic cancers.